Aprea Therapeutics (APRE) Misses Q4 EPS by 32c

Aprea Therapeutics (NASDAQ: APRE) reported Q4 EPS of ($0.32). Revenue for the quarter came in at $3.34 million.

For earnings history and earnings-related data on Aprea Therapeutics (APRE) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Lockheed Martin wins $153 million in defense contracts
• Is Treasury selloff a major issue for stock market bulls?